Mariko Muta

1.6k total citations · 1 hit paper
24 papers, 1.4k citations indexed

About

Mariko Muta is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mariko Muta has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Mariko Muta's work include Angiogenesis and VEGF in Cancer (9 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Chemokine receptors and signaling (3 papers). Mariko Muta is often cited by papers focused on Angiogenesis and VEGF in Cancer (9 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Chemokine receptors and signaling (3 papers). Mariko Muta collaborates with scholars based in Japan, United States and Germany. Mariko Muta's co-authors include Masakazu Toi, Hiroko Bando, Morio Koike, Takayuki Ueno, Katsumasa Kuroi, Hisashi Saji, Kouji Matsushima, Hidekuni Inadera, Gaku Matsumoto and T Ogawa and has published in prestigious journals such as Clinical Cancer Research, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Mariko Muta

24 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.

2000 617 citations Takayuki Ueno, Masakazu Toi et al. PubMed profile →

Peers

Countries citing papers authored by Mariko Muta

Since Specialization

Citations

This map shows the geographic impact of Mariko Muta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariko Muta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariko Muta more than expected).

Fields of papers citing papers by Mariko Muta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariko Muta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariko Muta. The network helps show where Mariko Muta may publish in the future.

Co-authorship network of co-authors of Mariko Muta

This figure shows the co-authorship network connecting the top 25 collaborators of Mariko Muta. A scholar is included among the top collaborators of Mariko Muta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariko Muta. Mariko Muta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Basic Fibroblast Growth Factor Is Essential to Maintain Endothelial Progenitor Cell Phenotype in TR-BME2 Cells 2014 ·Biological and Pharmaceutical Bulletin ·Yoshimichi Sai, Tomohiro Nishimura, Mariko Muta, Hisashi Iizasa, Takashi Miyata, Emi Nakashima	5
2	Genome-wide copy number analysis in primary breast cancer 2012 ·Expert Opinion on Therapeutic Targets ·Takayuki Ueno, Mitsuru Emi, Hidenori Sato, Noriko Ito, Mariko Muta, Katsumasa Kuroi, Masakazu Toi	22
3	Roles of TauT and system A in cytoprotection of rat syncytiotrophoblast cell line exposed to hypertonic stress 2010 ·Placenta ·Tomohiro Nishimura, Yoshimichi Sai, (unknown), Mariko Muta, Hisashi Iizasa, Masatoshi Tomi, (unknown), (unknown), (unknown)	20
4	Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells 2009 ·Oncology ·Mariko Muta, (unknown), Yoshimichi Sai, Shigehira Saji, Eiji Suzuki, Tomoyuki Aruga, Katsumasa Kuroi, Gaku Matsumoto, Masakazu Toi, Emi Nakashima	17
5	Tumor Size Significantly Correlates with Postoperative Liver Metastases and COX-2 Expression in Patients with Resectable Pancreatic Cancer 2007 ·Pancreatology ·Gaku Matsumoto, Mariko Muta, (unknown), Shinichiro Horiguchi, Katsuyuki Karasawa, Atsutake Okamoto	14
6	Altered Expression of Basement Membrane-related Molecules in Rat Brain Pericyte, Endothelial, and Astrocyte Cell Lines after Transforming Growth Factor-β1 Treatment 2007 ·Drug Metabolism and Pharmacokinetics ·(unknown), Tomoko Asashima, Mariko Muta, Hisashi Iizasa, Yoshimichi Sai, Tetsuya Terasaki, Emi Nakashima	30
7	A Nonfucosylated Anti-HER2 Antibody Augments Antibody-Dependent Cellular Cytotoxicity in Breast Cancer Patients 2007 ·Clinical Cancer Research ·Eiji Suzuki, Rinpei Niwa, Shigehira Saji, Mariko Muta, Makiko Hirose, Shigeru Iida, Yukimasa Shiotsu, Mitsuo Satoh, Kenya Shitara, Masahide Kondo, Masakazu Toi	91
8	Targeting of Nuclear Factor κB Pathways by Dehydroxymethylepoxyquinomicin, a Novel Inhibitor of Breast Carcinomas: Antitumor and Antiangiogenic Potential In vivo 2005 ·Clinical Cancer Research ·Gaku Matsumoto, (unknown), Mariko Muta, (unknown), Hiroko Bando, (unknown), Masakazu Toi, Kazuo Umezawa	78
9	Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo. 2005 ·PubMed ·Gaku Matsumoto, (unknown), Mariko Muta, (unknown), Hiroko Bando, (unknown), Masakazu Toi, Kazuo Umezawa	91
10	Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer 2004 ·British Journal of Cancer ·Masakazu Toi, Hiroko Bando, Shinichiro Horiguchi, Masahiro Takada, Akemi Kataoka, Takayuki Ueno, Shigehira Saji, Mariko Muta, Nobuaki Funata, Shinji Ohno	40
11	DFU, a selective COX-2 inhibitor, suppresses MCF-7 xenograft tumor growth in mice 2004 ·Oncology Reports ·(unknown), (unknown), Mariko Muta, (unknown), Hiroko Bando, Shigehira Saji, Koji Tsuruta, Atsutake Okamoto, Masakazu Toi	6
12	Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues 2003 ·Oncology Reports ·Yutaka Yamamoto, (unknown), Masakazu Toi, Mariko Muta, Shigenori E. Nagai, Nobuo Hanai, Akiko Furuya, Yoshio Osawa, Shigehira Saji, Michio Ogawa	15
13	Impact of vasculogenesis on solid tumor growth in a rat model 2003 ·Oncology Reports ·Mariko Muta, Gaku Matsumoto, Kiyoshi Hiruma, Shigehira Saji, Emi Nakashima, Masakazu Toi	9
14	Study of cancer gene therapy using IL-12-secreting endothelial progenitor cells in a rat solid tumor model 2003 ·Oncology Reports ·Mariko Muta, Gaku Matsumoto, Kiyoshi Hiruma, Emi Nakashima, Masakazu Toi	13
15	Expression of Macrophage Migration Inhibitory Factor in Human Breast Cancer: Association with Nodal Spread 2002 ·Japanese Journal of Cancer Research ·Hiroko Bando, Gaku Matsumoto, (unknown), Mariko Muta, T Ogawa, Nobuaki Funata, Jun Nishihira, Morio Koike, Masakazu Toi	92
16	Establishment of Bone Marrow-Derived Endothelial Cell Lines From ts-SV40 T-antigen Gene Transgenic Rats 2001 ·Pharmaceutical Research ·Kenji Hattori, Mariko Muta, Masakazu Toi, Hisashi Iizasa, (unknown), Tetsuya Terasaki, Masuo Obinata, Masatsugu Ueda, Emi Nakashima	17
17	Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor‐1 relationship in breast cancer 2001 ·International Journal of Cancer ·Masakazu Toi, Hiroko Bando, T Ogawa, Mariko Muta, (unknown), Herbert A. Weich	112
18	Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. breakdown → 2000 ·PubMed ·Takayuki Ueno, Masakazu Toi, Hisashi Saji, Mariko Muta, Hiroko Bando, Katsumasa Kuroi, Morio Koike, Hidekuni Inadera, Kouji Matsushima	617
19	Significance of Membrane Type 1 Matrix Metalloproteinase Expression in Breast Cancer 1999 ·Japanese Journal of Cancer Research ·Shinsuke Ishigaki, Masakazu Toi, Takayuki Ueno, Hiroshi Matsumoto, Mariko Muta, Morio Koike, Motoharu Seiki	28
20	Role of MDM2 Overexpression in Doxorubicin Resistance of Breast Carcinoma 1998 ·Japanese Journal of Cancer Research ·Akio Suzuki, Masakazu Toi, Yutaka Yamamoto, (unknown), Mariko Muta, (unknown)	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact